1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL SURGICAL SEALANTS MARKET BY TYPE
5.1. Introduction
5.2. Natural
5.2.1. Fibrin Sealants
5.2.2. Callogen Sealants
5.2.3. Others
5.3. Synthetic
5.3.1. Cyanoacrylate
5.3.2. Polyehtylene Glycol (PEG) Hydrogel
5.3.3. Others
5.4. Semi-Synthetic
5.4.1. Gelatin-Based
5.4.2. Albumin & Glutaraldehyde-Based
5.4.3. Lysine-Based
6. GLOBAL SURGICAL SEALANTS MARKET BY SURGERY TYPE
6.1. Introduction
6.2. Cardiovascular Surgery
6.3. Neurosurgery
6.4. General Surgery
6.5. Cosmetic Surgery
6.6. Thoracic Surgery
6.7. Other
7. GLOBAL SURGICAL SEALANTS MARKET BY APPLICATION
7.1. Introduction
7.2. Bleeding Control
7.3. Tissue Sealing & Repair
7.4. Air Sealing
8. GLOBAL SURGICAL SEALANTS MARKET BY END-USER
8.1. Introduction
8.2. Hospital
8.3. Ambulatory Surgical Centers
8.4. Others
9. GLOBAL SURGICAL SEALANTS MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Italy
9.4.5. Spain
9.4.6. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Israel
9.5.4. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. Japan
9.6.3. India
9.6.4. South Korea
9.6.5. Thailand
9.6.6. Taiwan
9.6.7. Indonesia
9.6.8. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Baxter International Inc.
11.2. Becton, Dickinson and Company
11.3. CollPlant Biotechnologies Ltd.
11.4. Artivion, Inc
11.5. CSL
11.6. Johnson & Johnson
11.7. Grifols, S.A.
11.8. SANYO CHEMICAL INDUSTRIES, LTD
11.9. B. Braun SE
11.10. Integra LifeSciences Corporation.
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES